Dark

RDHL
Redhill Biopharma Ltd.
stock NASDAQ ADR

At Close

May 8, 2025 3:59:30 PM EDT

1.98USD+3.459%(+0.07)40,206

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 8:58:30 AM EDT

1.85USD-3.334%(-0.06)1,924

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 13, 2022

11:53AM EST RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance Benzinga

11:51AM EST RedHill Biopharma' Says Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients Benzinga

10:35AM EST RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in PR Newswire

Jan 6, 2022

09:16AM EST RedHill Biopharma Reports License Deal With Gaelan Medical For Talicia For United Arab Emirates, No Terms Disclosed Benzinga

09:15AM EST RedHill Biopharma and Gaelan Medical Enter Into License Agreement for PR Newswire

Dec 20, 2021

08:35AM EST Life Sciences Companies Investor Presentations Now Available for On-Demand PR Newswire

Dec 15, 2021

09:17AM EST RedHill Biopharma Reports Members Of Its Board, Including Chair, CEO Collectively Purchased ~66K ADSs Of Co. Stock Since Mid October Benzinga

09:16AM EST RedHill Biopharma Announces Additional Insider Buying PR Newswire

Dec 9, 2021

09:46PM EST RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates For H. pylori Benzinga

12:20PM EST Life Sciences Virtual Investor Conference: Company Executives Present Live PR Newswire

07:01AM EST pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication PR Newswire

Dec 6, 2021

11:58AM EST RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations Benzinga

07:06AM EST Redhill's Says its Treatment for COVID-19 Pneumonia Likely Effective Against Omicron Benzinga

07:06AM EST RedHill Biopharma: Opaganib Mechanism Not Impacted By Viral Spike-Protein Mutations, Including Omicron Mutations RTTNews

07:01AM EST RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral PR Newswire

Dec 2, 2021

07:01AM EST RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of PR Newswire

Dec 1, 2021

07:23AM EST RedHill Biopharma's Movantik(r) Added as Preferred and Unrestricted Brand To PR Newswire

07:04AM EST RedHill Announced Movantik Added To Medicare Formulary Benzinga

Nov 30, 2021

04:47PM EST The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout Benzinga

04:43PM EST Redhill Biopharma Q3 EPS $(0.05) Beats $(0.21) Estimate, Sales $21.61M Miss $24.52M Estimate Benzinga

04:39PM EST Earnings Scheduled For November 30, 2021 Benzinga

04:06PM EST Earnings Preview For Redhill Biopharma Benzinga

07:15AM EST RedHill Biopharma Q3 Loss/shr $0.05 Same With Last Year RTTNews

07:03AM EST RedHill Biopharma Q3 Net Loss $21.4 Mln; Net Revenues $21.6 Mln RTTNews

07:01AM EST RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 PR Newswire

Nov 24, 2021

07:01AM EST RedHill Biopharma to Host Third Quarter 2021 Financial Results and Operational PR Newswire

Nov 23, 2021

11:10AM EST RedHill Biopharma Announces Closing of $15.5 Million Public Offering of PR Newswire

Nov 19, 2021

02:47PM EST Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble Benzinga

12:07PM EST Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge Benzinga

10:19AM EST Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views Benzinga

09:11AM EST RedHill Biopharma Prices 4.7M ADS Offering For Gross Proceeds Of $15.5M Benzinga

09:10AM EST RedHill Biopharma Announces Pricing of $15.5 Million Public Offering of PR Newswire

08:20AM EST The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial Benzinga

Nov 18, 2021

04:06PM EST RedHill Biopharma Reports Offering Of Common Stock, No Size Disclosed Benzinga

04:04PM EST RedHill Biopharma Announces Underwritten Public Offering of American Depositary PR Newswire

Nov 15, 2021

10:53AM EST RedHill Biopharma Announces Last Patient Randomized In Part A Of Ongoing Phase 2/3 COVID-19 Study Of Once-Daily Oral RHB-107 In Non-Hospitalized Patients Benzinga

07:02AM EST RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase PR Newswire

Nov 9, 2021

07:02AM EST RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference PR Newswire

Nov 8, 2021

07:17AM EST RedHill Biopharma, South Korea's Kukbo Announce Strategic Investment Of Up To $10M In RedHill Benzinga

07:15AM EST RedHill Biopharma Enters Strategic Agreement With Kukbo Co RTTNews

07:02AM EST RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment PR Newswire

Oct 25, 2021

07:06AM EDT RedHill Biopharma Highlights Presentation Of New Talicia And Movantik Data Analyses At ACG 2021 Benzinga

07:02AM EDT RedHill Biopharma Presents New Talicia(r) and Movantik(r) Data Analyses at ACG PR Newswire

Oct 21, 2021

12:12PM EDT Redhill Biopharma US Patent & Trademark Office Abstract For Co.'s 'SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION' Benzinga

Oct 20, 2021

07:04AM EDT RedHill Biopharma To Present At The BIO-Europe 2021 Conference Benzinga

Oct 19, 2021

08:33AM EDT David v Goliath in The Race to Develop an Oral Therapy for COVID-19 Benzinga

Oct 18, 2021

07:07AM EDT RedHill Biopharma Highlights Recent ADS Purchases By Management Benzinga

07:01AM EDT RedHill Biopharma Announces Insider Buying PR Newswire

Oct 12, 2021

07:22AM EDT RedHill Biopharma Ltd Announces New U.S. Patent For RedHill's Talicia For H.pylori Benzinga

07:15AM EDT RedHill Biopharma Announces U.S. Patent Covering Talicia For H. Pylori Infection Through 2034 RTTNews

07:01AM EDT RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori PR Newswire

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

07:04AM EDT RedHill Biopharma Ltd Announces Talicia(R) Added To Medi-Cal CDL Benzinga

07:01AM EDT RedHill Biopharma's Talicia(r) added to Medi-Cal Contract Drug List with No PR Newswire

05:47AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.35 A.M. EDT). RTTNews

Oct 4, 2021

08:26AM EDT RedHill Says Phase 2/3 Data Shows 62% Reduction In RTTNews

08:09AM EDT RedHill Biopharma Reports Further Analysis Of Phase 2/3 Data; Reports 62% Reduction In Mortality With Oral Opaganib In Moderately Severe COVID-19 Patients Benzinga

08:09AM EDT RedHill ; Phase 2/3 Data Shows 62% Reduction In Mortality With Oral Opaganib In Moderately Severe COVID-19 Patients RTTNews

08:01AM EDT Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients PR Newswire

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

09:43AM EDT RedHill Biopharma Files For U.S. Patent Titled 'SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTION' Benzinga

09:36AM EDT From BZ's Small Cap Healthcare Conference: RedHill Biopharma Chief Business Officer, Guy Goldberg Says Co Has Consistent Revenues Despite Of The Pandemic Condition, Co Is Planning To Grow Its Revenues Significantly In The Future Benzinga

09:35AM EDT From BZ's Small Cap Healthcare Conference: RedHill Biopharma Chief Business Officer, Guy Goldberg Says Co Has $71.5 Million In Cash On Hand Benzinga

09:30AM EDT From BZ's Small Cap Healthcare Conference: RedHill Biopharma Chief Business Officer, Guy Goldberg Begins Presenting Benzinga

Sep 25, 2021

11:21AM EDT TENX: Second Quarter Results Benzinga

Sep 23, 2021

11:12AM EDT RedHill Settles Movantik Patent Litigation With Aurobindo Benzinga

08:05AM EDT RedHill Biopharma Ltd. (RDHL), a specialty biopharmaceutical company, on Thursday, said RedHill Biopharma Inc., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics have entered into a settlement and license deal with Aurobindo Pharma USA, Inc. to resolve their patent litigation in the U.S. RTTNews

07:30AM EDT RedHill Biopharma Announces Settlement Of Movantik Patent Litigation With Aurobindo RTTNews

07:01AM EDT RedHill Biopharma Announces Settlement of Movantik(r) Patent Litigation with PR Newswire

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 15, 2021

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

06:08AM EDT HC Wainwright & Co. Maintains Buy on Redhill Biopharma, Lowers Price Target to $21 Benzinga

Sep 14, 2021

02:49PM EDT Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb Benzinga

12:27PM EDT Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide Benzinga

10:11AM EDT Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August Benzinga

08:36AM EDT RedHill Biopharma Ltd. (RDHL) reported preliminary top-line data from phase 2/3 study with opaganib in hospitalized patients with severe COVID-19 pneumonia. Preliminary top-line data showed that the study did not meet primary endpoint. Top-line safety data showed good tolerability of opaganib. RTTNews

08:21AM EDT RedHill Biopharma : Phase 2/3 Study Of Opaganib In Severe COVID-19 Patients Did Not Meet Primary Endpoint RTTNews

08:16AM EDT RedHill Biopharma Says While Preliminary Top-Line Data Of Opaganib Phase 2/3 Study Showed Consistent Trends; The Study Endpoints Did Not Achieve Statistical Significance Benzinga

08:15AM EDT RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe PR Newswire

08:10AM EDT Redhill Biopharma Shares Halted On Code News Pending Benzinga

Sep 13, 2021

09:10AM EDT RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa Benzinga

07:10AM EDT RedHill Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study Of Once-Daily Oral RHB-107 With South African Approval RTTNews

07:08AM EDT RedHill Biopharma Announces The South African Health Products Regulatory Authority Has Approved Phase 2/3 Study Of Once-Daily Oral RHB-107 In Non-Hospitalized Patients With Symptomatic COVID-19 Benzinga

07:01AM EDT Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval PR Newswire

Sep 7, 2021

07:56AM EDT RedHill Unveils New Movantik Data For Opioid-Induced Constipation Benzinga

07:04AM EDT RedHill Biopharma Highlights Results Of Preclinical Study Of Opaganib Benzinga

07:02AM EDT RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney PR Newswire

06:05AM EDT RedHill Biopharma Presents Three New Analyses Of Analyses Of Movantik Phase 3 Study Data At PAINWeek 2021 RTTNews

06:01AM EDT RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 PR Newswire

Sep 2, 2021

10:02AM EDT RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and PR Newswire

Aug 31, 2021

02:03PM EDT Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates Benzinga

11:44AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021 Benzinga

10:22AM EDT Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates Benzinga

06:49AM EDT Cantor Fitzgerald Initiates Coverage On Redhill Biopharma with Overweight Rating, Announces Price Target of $22 Benzinga

Aug 26, 2021

12:57PM EDT Redhill Biopharma shares were trading higher after the company reported better-than-expected Q2 EPS results. Benzinga

08:09AM EDT The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO Benzinga

07:55AM EDT Redhill Biopharma: Q2 Earnings Insights Benzinga

07:29AM EDT RedHill Biopharma Q2 Loss/shr $0.06 Vs. Loss/shr $0.04 Last Year RTTNews

07:06AM EDT Redhill Biopharma Q2 EPS $(0.06) Beats $(0.12) Estimate, Sales $21.50M Miss $25.02M Estimate Benzinga

07:01AM EDT RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational PR Newswire

06:30AM EDT RedHill Biopharma: Opaganib Shows Strong Inhibition Of RTTNews

06:08AM EDT RedHill Biopharma Says Opaganib Demonstrates Strong Inhibition Of COVID-19 Delta Variant RTTNews

06:02AM EDT RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant Benzinga

06:01AM EDT RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta PR Newswire

04:02AM EDT Earnings Scheduled For August 26, 2021 Benzinga

Aug 25, 2021

10:18AM EDT A Preview Of Redhill Biopharma's Earnings Benzinga

Aug 23, 2021

07:12AM EDT RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib For Ebola Virus And RHB-104 For Crohn's RTTNews

07:06AM EDT RedHill Biopharma Unveils Two New U.S. Patents Covering Opaganib For Ebola Virus And RHB-104 For Crohn's RTTNews

07:04AM EDT RedHill Biopharma Announces Two New US Patents Covering Opaganib For Ebola Virus And RHB-104 For Crohn's Benzinga

07:01AM EDT RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola PR Newswire

Aug 19, 2021

07:01AM EDT RedHill Biopharma to Host Second Quarter 2021 Financial Results and Operational PR Newswire

Aug 17, 2021

11:16AM EDT RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For 'Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine' Benzinga

11:15AM EDT CORRECTION: RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For 'Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine' Benzinga

11:12AM EDT RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For 'Compositions for treating ebola virus infection' Benzinga

09:35AM EDT RedHill Biopharma Ltd. Granted US Patent 'Compositions for treating ebola virus infection' Benzinga

Aug 4, 2021

12:55PM EDT Redhill Biopharma Option Alert: Sep 17 $7.5 Calls Sweep (80) near the Ask: 255 @ $1.0 vs 4163 OI; Earnings 8/16 Before Open [est] Ref=$7.0 Benzinga

12:36PM EDT Redhill Biopharma Option Alert: Sep 17 $5 Calls Sweep (14) near the Ask: 220 @ $2.4 vs 0 OI; Earnings 8/16 Before Open [est] Ref=$6.95 Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 23, 2021

10:18AM EDT Redhill Biopharma Option Alert: Sep 17 $7.5 Calls Sweep (11) near the Ask: 315 @ $1.1 vs 2507 OI; Earnings 8/12 Before Open [est] Ref=$6.935 Benzinga

Jul 22, 2021

09:21AM EDT RedHill Biopharma Announces Settlement Of Movantik Patent Litigation With Apotex RTTNews

09:21AM EDT UPDATE: RedHill Biopharma No Terms Disclosed For Litigation Benzinga

09:20AM EDT RedHill Biopharma Announces Settlement of Movantik(r) Patent Litigation with PR Newswire

09:20AM EDT RedHill Biopharma Reports Settlement Of Movantik Patent Litigation With Apotex Benzinga

Jul 20, 2021

07:07AM EDT RedHill Biopharma Reports Extension Of Unrestricted Commercial Coverage For Talicia With OptumRx Benzinga

07:01AM EDT RedHill Biopharma Significantly Extends Unrestricted Commercial Coverage for PR Newswire

Jul 19, 2021

07:08AM EDT RedHill Biopharma Announces Last Patient Out For Phase 2/3 COVID-19 Study Of Oral Opaganib RTTNews

07:01AM EDT RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of PR Newswire

Jul 13, 2021

11:02AM EDT RedHill Biopharma's Movantik(r) Added as Unrestricted Preferred Brand To A PR Newswire

11:01AM EDT Redhill Biopharma Says Co's Movantik Added As Unrestricted Preferred Brand To A Major National Commercial Formulary Serving Over 30M Americans Benzinga

Jun 28, 2021

08:00AM EDT RedHill Biopharma Ltd. (RDHL) Monday said Opaganib, the company's antiviral drug candidate for the treatment of Covid-19, showed strong inhibition against South African and Brazilian variants in preclinical study. RTTNews

07:10AM EDT RedHill Biopharma Says Opaganib Inhibits COVID-19 Variants In Preclinical Study RTTNews

07:02AM EDT RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study Benzinga

Jun 21, 2021

08:20AM EDT RedHill Biopharma Ltd. (RDHL) said that it has presented the positive phase 2 safety and efficacy data for oral opaganib or Yeliva, ABC294640 in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum 2021. RTTNews

07:17AM EDT RedHill Biopharma Presents Positive Oral Opaganib Phase 2 Data In COVID-19 At World Microbe Forum RTTNews

07:01AM EDT RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19 Benzinga

07:01AM EDT RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data PR Newswire

Jun 9, 2021

07:01AM EDT RedHill Biopharma to Present at the BIO Digital International Convention PR Newswire

Jun 7, 2021

07:07AM EDT RedHill Biopharma Completes Enrollment Of Oral Opaganib Phase 2/3 COVID-19 Study RTTNews

May 28, 2021

10:10AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021 Benzinga

07:56AM EDT WBB Securities Downgrades Redhill Biopharma to Buy, Lowers Price Target to $16 Benzinga

May 27, 2021

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

07:25AM EDT Redhill Biopharma: Q1 Earnings Insights Benzinga

07:19AM EDT RedHill Biopharma Q1 Loss Per Share $0.05, Flat With Last Year RTTNews

07:06AM EDT Redhill Biopharma Q1 EPS $(0.05) Beats $(0.34) Estimate, Sales $20.57M Miss $22.70M Estimate Benzinga

07:02AM EDT RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational PR Newswire

04:29AM EDT Earnings Scheduled For May 27, 2021 Benzinga

May 26, 2021

10:54AM EDT RedHill Biopharma Ltd. (RDHL) said that it has received two notices of allowance from the U.S. Patent and Trademark Office or USPTO covering opaganib and RHB-107 or upamostat as methods for the treatment of COVID-19 caused by the SARS-CoV-2 virus. RTTNews

10:38AM EDT Earnings Outlook for Redhill Biopharma Benzinga

07:12AM EDT RedHill Biopharma Gets Allowances From USPTO Covering Opaganib And RHB-107 For COVID-19 RTTNews

07:01AM EDT RedHill Biopharma Receives Allowances For US Patent Applications Covering Opaganib And RHB-107 For COVID-19 Benzinga

07:01AM EDT RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering PR Newswire

May 25, 2021

08:00AM EDT RedHill's Novel Late-Stage Pills Hold Promise Against COVID-19 and its Variants Benzinga

May 24, 2021

07:10AM EDT RedHill Biopharma Presents Analyses Of Movantik Onset Of Action And Symptom Improvement At DDW 2021 RTTNews

07:01AM EDT RedHill Biopharma Presents Analyses of Movantik Onset of Action and Symptom PR Newswire

May 21, 2021

12:18PM EDT RedHill Biopharma Presents A New Travelers' Diarrhea Clinical Severity Classification Tool And Its Use In Aemcolo Efficacy Analysis At DDW 2021 Benzinga

12:16PM EDT Classification Tool and its Use in Aemcolo Efficacy Analysis at DDW 2021 PR Newswire

May 20, 2021

07:01AM EDT RedHill Biopharma to Host First Quarter 2021 Financial Results and Operational PR Newswire

May 18, 2021

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 Benzinga

06:22AM EDT HC Wainwright & Co. Initiates Coverage On Redhill Biopharma with Buy Rating, Announces Price Target of $23 Benzinga

May 14, 2021

06:48AM EDT Schedule For Benzinga's Global Small Cap Conference Friday, May 14, 2021 Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

Apr 14, 2021

11:51AM EDT TENX: HELP Results & New Asset to Boot Benzinga

Apr 9, 2021

07:51AM EDT RedHill Biopharma Ltd. (RDHL) said the mid/late stage study of its Covid-19 drug candidate, Opaganib passed fourth review by an independent Data Safety Monitoring Board (DSMB). RTTNews

07:02AM EDT RedHill Reports Its Phase 2/3 COVID-19 Study Passed Fourth Data Safety Monitoring Board Review With Unanimous Recommendation To Continue Benzinga

07:02AM EDT RedHill Biopharma's Phase 2/3 COVID-19 Study Of Opaganib Gets Unanimous Recommendation To Continue RTTNews

07:01AM EDT RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB PR Newswire

Mar 30, 2021

08:06AM EDT RedHill Biopharma F-3 Shows Registration For ~7.15M ADS Offering Via Selling Shareholders Benzinga

Mar 27, 2021

08:14AM EDT 5 Israeli Stocks To Consider For Passover Benzinga

Mar 25, 2021

02:45PM EDT Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference Benzinga

09:17AM EDT RedHill Biopharma Reports Settlement Of Movantik Patent Litigation With MSN Pharmaceuticals RTTNews

09:16AM EDT RedHill Biopharma Reports Settlement Of Movantik Patent Litigation With MSN Pharma Benzinga

09:15AM EDT RedHill Biopharma Announces Settlement of Movantik(r) Patent Litigation with PR Newswire

Mar 24, 2021

02:39PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says 'The Need Is Clearly There' For COVID Therapeutics, Treatments Benzinga

02:39PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says 'COVID-19 Made A Lot Of Sense For Us To Go After' Benzinga

02:38PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says 'We Are Probably One Of The Only Companies In The World' With 2 Orally Administered COVID-19 Therapies Benzinga

02:37PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Highlights Data For RHB-104 For Crohn's Disease Benzinga

02:33PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Highlights Growth Of Co's Talicia 'Despite COVID Pandemic' Benzinga

02:31PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Highlights Future Drug Pipeline Benzinga

02:28PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Opaganib 'Completely Inhibited' SARS-CoV 2 Benzinga

02:27PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Both Of Co's COVID-19 Treatments 'Should Be Effective' Against Variants Benzinga

02:26PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Co's Treatments Have The Potential To Treat 'New Mutations' Of COVID-19 Variants Benzinga

02:26PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Co Has ' Two Shots On Goal' For COVID, Highlights Opaganib At 2/3 Enrollment; Highlights RHB-107 Phase 2/3 In Symptomatic Outpatients Ongoing Benzinga

02:24PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Expects 2021 To Be A 'Breakout Year' For Co Benzinga

02:24PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Highlights Balance Sheet, Rising Revenues Benzinga

02:24PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Says Co Already Has 'Several FDA Approved Products In U.S.,' Highlights 'Several Stage 3 Programs' Currently In Place Benzinga

02:22PM EDT From BZ Biotech Conference: RedHill Biopharma CEO Dror Ben-Asher Begins Presentation Benzinga

Mar 23, 2021

07:12PM EDT Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021 Benzinga

Mar 22, 2021

07:05AM EDT RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of First COVID-19 Patients in Switzerland Benzinga

07:01AM EDT RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first PR Newswire

Mar 18, 2021

08:18AM EDT Recap: Redhill Biopharma Q4 Earnings Benzinga

08:16AM EDT The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga

07:22AM EDT RedHill Biopharma Q4 Net Revenues $21.5 Mln RTTNews

07:07AM EDT Earnings Scheduled For March 18, 2021 Benzinga

07:02AM EDT Redhill Biopharma Q4 Sales $21.50M Miss $26.03M Estimate Benzinga

07:01AM EDT RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results PR Newswire

Mar 17, 2021

10:38AM EDT Earnings Preview for Redhill Biopharma Benzinga

Mar 16, 2021

12:03PM EDT Redhill Biopharma US Patent & Trademark Office Abstract For 'Method for treating cancer with combination therapy' Benzinga

Mar 11, 2021

07:01AM EST RedHill Biopharma to Host Fourth Quarter and Full Year 2020 Financial Results PR Newswire

Mar 5, 2021

07:01AM EST RedHill to Present at Upcoming Conferences in March PR Newswire

Mar 4, 2021

12:11PM EST RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of PR Newswire

Mar 3, 2021

08:58AM EST Mid-Afternoon Market Update: Crude Oil Down 1.5%; Communication Systems Shares Spike Higher Benzinga

08:58AM EST Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher Benzinga

Mar 2, 2021

02:57PM EST Mid-Afternoon Market Update: Crude Oil Down 1.5%; Communication Systems Shares Spike Higher Benzinga

12:11PM EST Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher Benzinga

09:12AM EST ObvioHealth And RedHill Announce Launch O Trial For ObvioHealth and RedHill Benzinga

09:07AM EST ObvioHealth And RedHill Biopharma Launch First In Kind Remote COVID-19 Therapy Trial Incorporating RTTNews

09:06AM EST ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy PR Newswire

08:26AM EST RedHill Biopharma Increases Previously Announced Bought Deal Offering To $35M; 4.375M Shares At $8/Share Benzinga

08:23AM EST RedHill Biopharma Increases Previously Announced Bought Deal to $35 Million of PR Newswire

08:01AM EST The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data Benzinga

Mar 1, 2021

04:55PM EST RedHill Biopharma Announces $10M Bought Deal Offering Of American Depositary Shares; 1.25M Shares At $8/Share Benzinga

04:53PM EST RedHill Biopharma Announces $10 Million Bought Deal Offering of American PR Newswire

Feb 23, 2021

08:07AM EST RedHill Biopharma Expands Opaganib Global COVID-19 Study To US Benzinga

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

07:17AM EST RedHill Biopharma Plans To Expand Phase 2/3 Study Of Opaganib In Patients With Severe COVID-19 To The U.S. RTTNews

07:08AM EST RedHill Biopharma Announces Planned Expansion Of Opaganib Global Phase 2/3 COVID-19 Study To The US Benzinga

07:04AM EST RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 PR Newswire

Feb 18, 2021

01:00PM EST RedHill Biopharma, Cosmo Pharma In Manufacturing Pact for Movantik, RHB-204 Benzinga

07:19AM EST RedHill Biopharma Says Strengthens Partnership With Cosmo Pharmaceuticals With Manufacturing Agreement For Movantik And RHB-204; Terms Not Disclosed Benzinga

07:15AM EST RedHill Biopharma, Cosmo Pharma Sign Manufacturing Agreements For Movantik And RHB-204 RTTNews

07:01AM EST RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with PR Newswire

Feb 17, 2021

07:22AM EST RedHill Biopharma Says First Patient Dosed In U.S. Phase 2/3 COVID-19 Outpatient Study With RHB-107 RTTNews

07:13AM EST RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107 Benzinga

07:10AM EST RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 PR Newswire

Feb 9, 2021

07:01AM EST RedHill Biopharma to Present at SVB Leerink Global Healthcare and BIO CEO & PR Newswire

Jan 29, 2021

07:45AM EST The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO Benzinga

07:03AM EST RedHill Biopharma Announces Data Safety Monitoring Board For Co.'s Phase 2/3 Trial Of Opaganib Recommended To Continue Study Benzinga

07:01AM EST RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 PR Newswire

Jan 28, 2021

08:07AM EST RedHill Biopharma Ltd. (RDHL) said that it has reached an agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study. RTTNews

07:32AM EST RedHill Biopharma Announces Manufacturing Deal With Cosmo Pharma To Further Expand Manufacturing Capacity For Opaganib RTTNews

07:30AM EST RedHill Biopharma Announces Manufacturing Agreement With Cosmo Pharmaceuticals To Expand Manufacturing Capacity Of opaganib Benzinga

07:28AM EST RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 PR Newswire

Jan 27, 2021

05:29AM EST Pre-market Movers In Healthcare Sector: TMBR, AEZS, SRNE, RTTNews

Jan 26, 2021

08:43AM EST RedHill Biopharma Issued U.S. Patent 10,898,439 'Methods for treating helicobacter pylori infection' Benzinga

Jan 14, 2021

02:14PM EST RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering PR Newswire

Jan 12, 2021

02:31PM EST Mid-Afternoon Market Update: Dow Rises 50 Points; Qilian International Shares Spike Higher Benzinga

12:27PM EST Mid-Day Market Update: VOXX International Jumps Following Q3 Earnings; RedHill Biopharma Shares Slide Benzinga

09:02AM EST RedHill Biopharma Raises Previously Announced Bought Deal To $25 Mln RTTNews

08:52AM EST RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million PR Newswire

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 11, 2021

04:39PM EST RedHill Biopharma Announces That It Agreed To Buy 1.275M ADS At $7.84 Per ADS Benzinga

04:36PM EST RedHill Biopharma Announces $10 Million Bought Deal Offering PR Newswire

07:15AM EST RedHill's Partner Cosmo Pharma Completes Phase 2 Study Of Rifamycin SV-MMX 600mg In IBS-D RTTNews

07:01AM EST RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of PR Newswire

Jan 6, 2021

07:29AM EST RedHill Biopharma: FDA Grants Fast Track Designation To RTTNews

07:12AM EST RedHill's RHB-204 Granted FDA Fast Track Designation For NTM Disease RTTNews

07:02AM EST RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease Benzinga

Dec 31, 2020

10:06AM EST RedHill Biopharma Ltd. (RDHL) said that preliminary data from its U.S. Phase 2 study with orally-administered opaganib in patients hospitalized with COVID-19 pneumonia demonstrated positive safety and efficacy signals. RTTNews

09:34AM EST RedHill Biopharma Reports Preliminary Top-line Data From U.S. Phase 2 Study With Orally-administered Opaganib RTTNews